Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

• Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP (2008) Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacology & therapeutics 117: 244-79.

  View at Publisher | View at Google Scholar

• Wrobleski ST, Lin S, Hynes J, Wu H, Pitt S, et al. (2008) Synthesis and SAR of new pyrrolo [2, 1-f][1, 2, 4] triazines as potent p38α MAP kinase inhibitors. Bioorganic & medicinal chemistry letters 18: 2739-44.

  View at Publisher | View at Google Scholar
• Dell’Agnello G, Zuddas A, Masi G, Curatolo P, Besana D, et al. (2009) Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions. CNS drugs 23:739-753.
  View at Publisher | View at Google Scholar

• Sieper J, Rudwaleit M, Braun J (2007) Adalimumab for the treatment of ankylosing spondylitis. Expert opinion on pharmacotherapy 8: 831-8.

  View at Publisher | View at Google Scholar
• Turgay A, Ansari R (2006) Major depression with ADHD: in children and adolescents. Psychiatry (Edgmont). 3:20.
  View at Publisher | View at Google Scholar

• Mease PJ (2007) Adalimumab in the treatment of arthritis. Therapeutics and clinical risk management 3: 133.

  View at Publisher | View at Google Scholar
• Gökçen C, Kutuk MO, CoÅŸkun Åž (2013) Dose-dependent Raynaud's phenomenon developing from use of atomoxetine in a girl. Journal of child and adolescent psychopharmacology. 23:428-430.
  View at Publisher | View at Google Scholar

• Papadakis KA (2006) Adalimumab for the treatment of Crohn’s disease. Expert review of clinical immunology 2: 11-5.

  View at Publisher | View at Google Scholar
• Whitlock GA, Andrews MD, Brown AD, Fish PV, Stobie A, et al. Design of monoamine reuptake inhibitors: SSRIs, SNRIs and NRIs. InTransporters as Targets for Drugs 2008 (pp. 53-94). Springer Berlin Heidelberg.
  View at Publisher | View at Google Scholar
• Turgay A. A multidimensional approach to medication selection in the treatment of children and adolescents with ADHD. Psychiatry (Edgmont). 4:47.
  View at Publisher | View at Google Scholar

• Nakao A, Ohkawa N, Nagasaki T, Kagari T, Doi H, et al. (2009) Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: Part 1. Bioorganic & medicinal chemistry letters 19: 4607-10.

  View at Publisher | View at Google Scholar

• Hasani-Ranjbar S, Nayebi N, Larijani B and Abdollahi M, 2009. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol, 15(25), pp.3073-3085.

  View at Publisher | View at Google Scholar

• Hasani-Ranjbar S, Larijani B and Abdollahi M, (2009). A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets-Inflammation & Allergy), 8(1), pp.2-10.

  View at Publisher | View at Google Scholar
• Kooij JS (2011) Medication management in adult ADHD. ADHD in Adults: Characterization, Diagnosis, and Treatment. 3:218.
  View at Publisher | View at Google Scholar
• Benkert D, Krause KH, Wasem J, Aidelsburger P (2010) Drug treatment of ADHD (attention-deficit/hyperactivity disorder) in adults in Germany. DIMDI HTA report. 108e.
  View at Publisher | View at Google Scholar
• Dell’Agnello G, Zuddas A, Masi G, Curatolo P, Besana D, et al. Uso de atomoxetina en pacientes con trastorno por déficit de atención con hiperactividad y condiciones comórbidas. CNS Drugs. 2009;23(9):739-53.
  View at Publisher | View at Google Scholar

• Hribar G, Žnidaršič A, Bele M, Maver U, Caserman S, et al. (2011)  Zinc-phosphate nanoparticles with reversibly attached TNF-α analogs: an interesting concept for potential use in active immunotherapy. Journal of Nanoparticle Research13: 3019-3032.

  View at Publisher | View at Google Scholar

• Nakao A, Ohkawa N, Nagasaki T, Kagari T, Doi H, et al. (2010) Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: Part 3. Bioorganic & medicinal chemistry letters 20:4774-4778.

  View at Publisher | View at Google Scholar

• Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF,et al. (2009) Clinical practice guidelines for the management candidiasis: 2009 update by the Infectious Diseases Society of America. Clinical infectious diseases. 48:503-535.

  View at Publisher | View at Google Scholar
• Butler MS (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Natural product reports. 25:475-516.
  View at Publisher | View at Google Scholar

• Salfeld J, Kupper H (2007) Adalimumab. InBiologics in general medicine 14-31

  View at Publisher | View at Google Scholar
• Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, et al. (2007) Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clinical infectious diseases. 45: 883-893.
  View at Publisher | View at Google Scholar
• Singh N, Paterson DL (2005) Aspergillus infections in transplant recipients. Clinical microbiology reviews. 18: 44-69.
  View at Publisher | View at Google Scholar

• Stefan A, Conti M, Rubboli D, Ravagli L, Presta E, et al. (2011) Overexpression and purification of the recombinant diphtheria toxin variant CRM197 in Escherichia coli. Journal of biotechnology 156: 245-252.

  View at Publisher | View at Google Scholar
• Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, et al. (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clinical infectious diseases. cis021.
  View at Publisher | View at Google Scholar

• Buzzi S, Buzzi G, Buzzi AM, Martini S. CRM197: reduction of atherosclerotic stenoses in carotids of three elderly patients.

  View at Publisher | View at Google Scholar
• Chen SC, Slavin MA, Sorrell TC (2011) Echinocandin antifungal drugs in fungal infections. Drugs. 71: 11-41.
  View at Publisher | View at Google Scholar
• Queiroz-Telles F, Berezin E, Leverger G, Freire A, van der Vyver A, et al. (2008) Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. The Pediatric infectious disease journal. 27:820-826.
  View at Publisher | View at Google Scholar

• Wang M, Wei Y, Ma B, Huang Z, Lu W, et al. (2014) Optimization of Reproducibility and Purification Process of Recombinant Diphtheria Toxin Noncombustant Mutant CRM_ (197). Chinese Journal of Biologicals 7: 021.

  View at Publisher | View at Google Scholar
• Méan M, Marchetti O, Calandra T (2008) Bench-to-bedside review: Candida infections in the intensive care unit. Critical care. 12:204.
  View at Publisher | View at Google Scholar

• Breuer K, Werfel T, Kapp A (2005) Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis. American journal of clinical dermatology 6: 65-77.

  View at Publisher | View at Google Scholar
• Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, et al. (2015) Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clinical Infectious Diseases. civ933.

   

  View at Publisher | View at Google Scholar

• Breuer K, Werfel T, Kapp A (2005) Allergic manifestations of skin diseases–atopic dermatitis. InAllergy and Asthma in Modern Society: A Scientific Approach 91: 76-86

  View at Publisher | View at Google Scholar
• Lai CC, Tan CK, Huang YT, Shao PL, Hsueh PR (2008) Current challenges in the management of invasive fungal infections. Journal of Infection and Chemotherapy. 14:77-85.
  View at Publisher | View at Google Scholar

• Wirantari N, Prakoeswa CR (2014) Penggunaan Kalsineurin Inhibitor sebagai Imunomodulator Topikal pada Terapi Dermatitis Atopik. Berkala Ilmu Kesehatan Kulit dan Kelamin 26: 1-7.

  View at Publisher | View at Google Scholar

• Fröschl B, Arts D, Leopold C. Topische antientzündliche Behandlung der Neurodermitis im Kindesalter.

  View at Publisher | View at Google Scholar

• Razavi MK, Karmouta E (2014) Catheter-Based Therapies for Deep Vein Thrombosis. Current cardiology reports 16: 1-6.

  View at Publisher | View at Google Scholar

• Loney-Hutchinson LM, McFarlane SI. Glycemic control for hospitalized patients with diabetes: strategies for effective management.

  View at Publisher | View at Google Scholar

• Wilbur K, Yu C (2007) Evaluation of a standardized sliding scale insulin preprinted order. Journal of Pharmacy Technology 23: 135-41.

  View at Publisher | View at Google Scholar

• McFarlane SI, Gliwa A, Bubb C, Joseph L, Arora S, et al. (2006) Predictors of sliding scale insulin use by housestaff physicians in the management of hospitalized patients with diabetes mellitus 395-398

  View at Publisher | View at Google Scholar

• Fung LK, Mahajan R, Nozzolillo A, Bernal P, Krasner A, et al. (2016) Pharmacologic treatment of severe irritability and problem behaviors in autism: a systematic review and meta-analysis. Pediatrics 137: S124-35.

  View at Publisher | View at Google Scholar

• Wetzstein HG (2005) Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance. Antimicrobial agents and chemotherapy 49: 4166-4173.

  View at Publisher | View at Google Scholar

• Goessens WH, Mouton JW, Ten Kate MT, Bijl AJ, Ott A, et al. (2007) Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection. Journal of antimicrobial chemotherapy 59: 507-516.

  View at Publisher | View at Google Scholar
• Andes D, Diekema DJ, Pfaller MA, Bohrmuller J, Marchillo K,et al. (2010) In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species. Antimicrobial agents and chemotherapy. 54: 2497-2506.
  View at Publisher | View at Google Scholar

• Hedlin P, Blondeau JM (2007) Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae. Eye & contact lens 33: 161-164.

  View at Publisher | View at Google Scholar
• Shao PL, Huang LM, Hsueh PR (2007) Recent advances and challenges in the treatment of invasive fungal infections. International journal of antimicrobial agents. 30:487-495.
  View at Publisher | View at Google Scholar

• Blondeau Joseph M,Glenn S. Tillotson (2005) "Antibiotic dosing: do we dose to cure the individual or do we treat the greater societal needs? 511-516.

  View at Publisher | View at Google Scholar
• Andes D, Diekema DJ, Pfaller MA, Prince RA, Marchillo K, et al. (2008) In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model. Antimicrobial agents and chemotherapy. 52:539-550.
  View at Publisher | View at Google Scholar
• Singh N, Husain S (2009) Invasive aspergillosis in solid organ transplant recipients. American Journal of Transplantation. 9(s4): S180-91.
  View at Publisher | View at Google Scholar

• Daniels JB, Tracy G, Irom SJ, Lakritz J (2014) Fluoroquinolone levels in healthy dog urine following a 20‐mg/kg oral dose of enrofloxacin exceed mutant prevention concentration targets against Escherichia coli isolated from canine urinary tract infections. Journal of veterinary pharmacology and therapeutics 37: 201-204.

  View at Publisher | View at Google Scholar